Alzheimers Drug Discovery Foundation
Donations deductibleAlzheimers Drug Discovery Foundation's network
23 people5 organisationsi23 people and 5 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (23). Violet dotted lines (5) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
23 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 23 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Leonard A Lauder Chair (also filed as Leonard Lauder) | Co-Chairman /Governor | 2018 | 8 yrs |
| Ronald S Lauder Chair (also filed as Ronald Lauder) | Co-Chairman /Governor | 2018 | 8 yrs |
| Sandra Day O'Connor Chair | Honorary Chairman | 2020 | 6 yrs |
| Alice Shure | Governor | 2018 | 8 yrs |
| Beatriz Illescas Putzeys-Claugus | Governor | 2022 | 4 yrs |
| Bonnie Pfeifer Evans | Governor | 2018 | 8 yrs |
| David Weinreb | Governor | 2020 | 6 yrs |
| Gary M Lauder | Governor | 2018 | 8 yrs |
| Howard Fillit MD | Founding Exec. Dir. & Chief Sci. Off. | 2018 | 8 yrs |
| Lanny Edelsohn MD | Governor | 2018 | 8 yrs |
| Laurence C Leeds Jr (also filed as Laurence Leeds JR) | Governor | 2018 | 8 yrs |
| Melvin Goodes | Honorary Governor | 2022 | 4 yrs |
| Miia Kivipelto MD PHD | Governor | 2022 | 4 yrs |
| Nancy Corzine | Governor | 2018 | 8 yrs |
| Nancy Goodes | Governor | 2018 | 8 yrs |
| Paula Zahn | Governor | 2018 | 8 yrs |
| Randal Sandler | Co-Vice Chairman & Secretary | 2018 | 8 yrs |
| Richard Mohs PHD | Governor | 2018 | 8 yrs |
| Robert A Belfer (also filed as Robert Belfer) | Governor | 2018 | 8 yrs |
| Roberta Diaz Brinton PHD (also filed as Roberta Diaz Brinton) | Governor | 2018 | 8 yrs |
| Sharon Sager | Governor | 2020 | 6 yrs |
| Thomas F McWilliams (also filed as Thomas McWilliams) | Co-Vice Chairman & Treasur | 2018 | 8 yrs |
| Thomas Smith JR | Governor | 2022 | 4 yrs |
Officers and senior leadership
12 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Aaron Burstein | Head of Search and Evaluation | 2023 |
| Christopher Carlson | Director, Search & Evaluation | 2023 |
| Jane McIntosh | Chief External Affairs and Philanthropy Officer | since 2022 |
| Jennifer S Iselin | Director, Special Events (Outgoing) | 2022 |
| Karen Harris | CFO and Head of Mission Relate | since 2022 |
| Kevin Dieterich | Treasurer | since 2018 |
| Lakita Cavin | Attorney, Mission-Related Investments | 2023 |
| Laura Nisenbaum | Executive Director, Drug Development | since 2022 |
| Lisa Somar | Asst Treas/Sec | since 2018 |
| Marina D'Emic | Director of Finance | 2022 |
| Mark Roithmayr | CEO | since 2018 |
| Sarah Giardina | Associate Director, Dxa | 2022 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Howard Fillit MD | Founding Exec. Dir. & Chief Science Off. | 40 | $663k | $35k | |
| Mark Roithmayr | CEO | 40 | $651k | $41k | |
| Laura Nisenbaum | Executive Director, Drug Development | 40 | $443k | $37k | |
| Jane McIntosh | Chief External Affairs | 40 | $378k | $14k | |
| Karen Harris | CFO and Head of Mission Related Inv | 40 | $369k | $26k | |
| Aaron Burstein | Head of Search and Evaluation | 40 | $314k | $54k | |
| Eli Shobin | Senior Director Dxa | 40 | $236k | $34k | |
| Lakita Cavin | Attorney, Mission-Related | 40 | $220k | $21k | |
| Adam Hoffman | Governor | 1 | $0 | ||
| Alice Shure | Governor | 1 | $0 | ||
| Ann Jackson | Governor | 1 | $0 | ||
| Bonnie Englebardt Lautenberg | Governor | 1 | $0 | ||
| Bonnie Pfeifer Evans | Governor | 1 | $0 | ||
| Carol Boulanger | Governor | 1 | $0 | ||
| David Weinreb | Governor | 1 | $0 | ||
| Gary M Lauder | Governor | 1 | $0 | ||
| Henrik Zetterberg MD PhD | Governor | 1 | $0 | ||
| Julieann Shanahan Cfa | Governor | 1 | $0 | ||
| Lanny Edelsohn MD | Governor | 1 | $0 | ||
| Laura Steele | Governor | 1 | $0 | ||
| Laurence Leeds Jr | Governor | 1 | $0 | ||
| Leonard Lauder | Co-Chairman /Governor (Deceased) | 1 | $0 | ||
| Miia Kivipelto MD PhD | Governor | 1 | $0 | ||
| Nancy Corzine | Governor | 1 | $0 | ||
| Nancy Goodes | Governor | 1 | $0 | ||
| Niranjan Bose PhD | Governor | 1 | $0 | ||
| Paula Zahn | Governor | 1 | $0 | ||
| Philip Scheltens MD PhD | Governor | 1 | $0 | ||
| Rachid Izzar | Governor | 1 | $0 | ||
| Randal Sandler | Co-Vice Chairman & Secretary | 1 | $0 | ||
| Ric Edelman | Governor | 1 | $0 | ||
| Richard Mohs PhD | Governor | 1 | $0 | ||
| Roberta Diaz Brinton PhD | Governor | 1 | $0 | ||
| Ronald Lauder | Co-Chairman /Governor | 1 | $0 | ||
| Sharon Sager | Governor | 1 | $0 | ||
| Thomas McWilliams | Co-Vice Chairman & Treasurer | 1 | $0 | ||
| Thomas Smith Jr | Governor | 1 | $0 |
Colorado roster
25 listediOfficers, directors and trustees from the latest filing with the Colorado Secretary of State (document 20253017823). Titles are as filed; some entries are registered agents or custodians of records rather than board members. Source: data.colorado.gov, public domain.| Name | Title as filed |
|---|---|
| Thomas F. McWilliams | Co Vice Chairman, Treasurer |
| Leonard Lauder | Co-Chairman |
| Mark Roithmayr | CEO |
| Lanny Edelsohn | Director |
| Sally Susman | Honorary Governer |
| Randal Sandler | Co Vice Chairman, Secretary |
| Sandra Day O'conner | Honorary Chairman |
| Beatriz Illescas | Director |
| Nancy Corzine | Director |
| Laurence C. Leeds | Director |
| Alice Shure | Director |
| Paula Zahn | Director |
| David Weinreb | Director |
| Bonnie Pfeifer Evans | Director |
| Ronald Lauder | Co-Chairman |
| Howard Fillit MD | Ex Officio |
| Nancy Goodes | Director |
| Roberta Diaz-Brinton | Director |
| Karen Harris | CFO |
| Melvin Goodes | Honorary Director |
| Karen Harris | |
| Gary Lauder | Director |
| Marina D'emic | Controller |
| Miia Kivipelto | Director |
| Robert Belfer | Director |
About
- Legal name
- Alzheimers Drug Discovery Foundation
- EIN
- 201082179
- Address
- 57 W 57th St Ste 904, New York, NY, 10019-2819
- State
- New York
- Mission
- Accelerate the discovery of drugs to prevent, treat and cure alzheimer's disease and related dementias. (as filed on the Form 990)
- Activity (NTEE)
- V36 Social science research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Social Science
- Size band
- 9 (IRS master file code)
- Formed
- 2004
- Principal officer
- Howard Fillit MD (as named on the Form 990)
- IRS ruling date
- 1 September 2005
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 5, latest 2023
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥8years on the filingsLeonard A Lauder
≥8years on the filingsRonald S Lauder
≥8years on the filingsAlice Shure
≥8years on the filingsBonnie Pfeifer Evans
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $299.4m
- Total liabilities
- $82.4m
- Net assets or fund balances
- $217m
- Contributions and grants received
- $36m
- Program service revenue
- $5.8m
- Grants and similar paid out
- $73.3m
- Employees
- 48
- Volunteers
- 28
Grants paid
25+ listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Alamar Biosciences | Alzheimers research | $10m |
| C2N Diagnostics | Alzheimers research | $7m |
| Pharmatrophix | Alzheimers research | $5.6m |
| Coya Therapeutics | Alzheimers research | $5m |
| Metro International Biotechedenroc | Alzheimers research | $5m |
| Modulo Bio Inc | Alzheimers research | $4.8m |
| University of Nevada Las Vegas | Alzheimers research | $3.2m |
| Aquinnah Pharmaceuticals | Alzheimers research | $3m |
| Davos Alzheimers Collaborative | Alzheimers research | $2.5m |
| University of Arizona - Health Sciences | Alzheimers research | $1.8m |
| Vaccinex | Alzheimers research | $1.8m |
| Viewmind | Alzheimers research | $1.4m |
| Esya Inc | Alzheimers research | $789k |
| Trustees of Indiana University | Alzheimers research | $600k |
| University of Minnesota | Alzheimers research | $494k |
| Clearview Healthcare Partners | Alzheimers research | $272k |
| Johns Hopkins University | Alzheimers research | $270k |
| Neurotherapia Inc | Alzheimers research | $250k |
| University of Kansas Medical Center | Alzheimers research | $250k |
| Neuroage Therapeutics | Alzheimers research | $250k |
| Mti Biotech Inc | Alzheimers research | $159k |
| Trustees of Boston University | Alzheimers research | $150k |
| Usagainstalzheimer's Network | Alzheimers research | $65k |
| The Milken Institute | Alzheimers research | $25k |
| Global Alzheimer's Platform Foundation | Alzheimers research | $20k |